4//SEC Filing
Longpre Lara 4
Accession 0001209191-23-006312
CIK 0001759425other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:46 PM ET
Size
7.2 KB
Accession
0001209191-23-006312
Insider Transaction Report
Form 4
Longpre Lara
Chief Development Officer
Transactions
- Award
Common Stock
2023-01-31+9,625→ 106,159 total - Award
Stock Option (right to buy)
2023-01-31+38,500→ 38,500 totalExercise: $23.48Exp: 2033-01-30→ Common Stock (38,500 underlying)
Footnotes (2)
- [F1]Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan.
- [F2]1/4th of the shares vest one year after January 31, 2023 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
Documents
Issuer
Mirum Pharmaceuticals, Inc.
CIK 0001759425
Entity typeother
Related Parties
1- filerCIK 0001780347
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:46 PM ET
- Size
- 7.2 KB